NCT05539937View on ClinicalTrials.gov

Prospective Evaluation of the Quality of Life of Elderly Patients Undergoing Transfemoral Percutanous Aortic Valve Replacement (TAVI) for the Treatment of Severe Aortic Stenosis.

RecruitingOBSERVATIONAL
Enrollment

140

Participants

Timeline

Start Date

March 21, 2023

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Quality of LifeAortic Valve ReplacementTransfemoral Approach
Interventions
OTHER

Quality of life questionnaire

Before TAVI, 30 days, 6 months and twelve months after TAVI, patients will answer TASQ questionnaire,

Trial Locations (1)

77000

RECRUITING

Jean-François Oudet, La Rochette

Sponsors

Lead Sponsor

Elsan
All Listed Sponsors
collaborator

Belledonne clinic

UNKNOWN

collaborator

European Clinical Trial Experts Network

OTHER

lead

Elsan

OTHER

NCT05539937 - Prospective Evaluation of the Quality of Life of Elderly Patients Undergoing Transfemoral Percutanous Aortic Valve Replacement (TAVI) for the Treatment of Severe Aortic Stenosis. | Biotech Hunter | Biotech Hunter